Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Orthopedic Device Firms Lobby Hard On COVID-19 Relief And Reimbursements, Among Other Issues

Executive Summary

Firms including Depuy Synthes, Medtronic Inc., and Zimmer Biomet Holdings Inc., spent thousands of dollars lobbying Congress last winter.

You may also be interested in...

HHS Conditions Hospital COVID-19 Relief Payments On No Surprise Billing

A new US HHS report highlights ways the agency and coronavirus relief legislation are seeking to prevent high-cost surprise billing of patients with the novel coronavirus.

COVID-19: AdvaMed Asks USTR To Drop Tariffs On More Chinese Medtech Products

The largest medtech industry group has asked the Office of the US Trade Representative to waive tariffs on more medical devices imported from China as the US fights the COVID-19 crisis. AdvaMed wants an indefinite waiver, or at least one that extends a year beyond when the WHO declares an end to the pandemic.

Latest Coronavirus Bill Passage Adds $100Bn To National Testing Effort

With US House passage of a $484bn coronavirus relief package late on 23 April, Congress has allocated another substantial chunk of funding to support nationwide COVID-19 testing. President Trump signed the bill midday on 24 April.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts